All Episodes
EHA Unplugged — 191 episodes
CAR-T for Pediatric B-ALL: Expert Tips
Getting Patients to CAR T: Referral Systems in Europe
Outpatient CAR T in Europe: Lessons from Barcelona
Smarter CARs: Using AI to Improve Chimeric Antigen Receptor Design
What is Real-World Evidence Revealing About CAR T Therapy?
Hematology Portraits: Prof Frank Leebeek
How to Start a Clinical Trial?
How Experts Treat Multiple Myeloma
Where Are We Now With Immunotherapy in Multiple Myeloma?
Menin Inhibitors to Treat Acute Myeloid Leukemia (AML)
How Experts Treat HIV-associated Lymphomas
Hematology Portraits: Associate Prof Meritxell Alberich Jordà
How Experts Treat Large B-cell Lymphoma (LBCL)
Connecting Hematology Research and Real Life: Peter Kapitein
How Experts Treat Peripheral T- and NK-cell Lymphomas
Hematology Portraits: Prof Konstanze Döhner
How Blood Cells Age: From Stem Cells to Clones (with Dr Michael Milsom)
How Experts Treat Mantle Cell Lymphoma (with Prof Mats Jerkeman)
Life After CAR T-cell Therapy: Jonathan Clark’s Journey with Mantle Cell Lymphoma and the Future of Patient Advocacy
The Role of Artificial Intelligence in Hematology (featuring Dr Gregor Hormann)
How Does Climate Change Affect Hematology Practice? (with Dr Stephen Hibbs)
Accelerating Clinical Trials with AI (with Dr Jan Moritz Middeke)
EHA Junior Research Grant: Dr Ana Río-Machín’s Journey in AML Research and Collaborative Science
Hematologists’ Role in the Management of Gaucher Disease (Prof Argiris Symeonidis and Prof Sam Salek)
Navigating the Toughest Challenges in Hematology Nursing: Insights from HNHCP Leaders
A Multiple Myeloma and MRD Pioneer: EHA 2025 Lifetime Achievement Award (Prof Jesús San-Miguel)
Young Hematologists in the Spotlight: EHA2025 Young EHA Award (Dr Mandy Lauw)
Supporting Hematology Innovation: Outcomes of an EHA Junior Research Grant (with Dr Ferran Nadeu Prat)
Ethical Considerations in Gene Therapy for Sickle Cell Disease and Thalassemia (with Prof Mariane de Montalembert)
Point-of-care Tests for Neonatal Screening of Sickle Cell Disease (with Prof Béatrice Gulbis)
What the EHA Burnout Survey Reveals for Hematologists (with Dr. Côme Bommier)
EHA2025 Diversity, Equity, and Inclusion Award: Prof Anna Schuh
A Successful Mentor’s Mindset: EHA2025 Education & Mentoring Award (Prof Jan Cools)
EHA Clinical Excellence Award 2025: Prof Khaled Musallam
Setting the Standard for Quality Care in Hematologic Malignancies (with Prof John Gribben)
Hematology Portraits: Prof Kirsten Grønbæk
Hematology Portraits: Prof Maria Domenica Cappellini
Gene Therapy Advances in SCD and B-Thalassemia (with Dr Stefano Rivella)
AML Management in the Old and Unfit (with Prof Hartmut Döhner)
Managing Young Fit AML patients with Prof Konstanze Döhner
GoCART Coalition (with Prof Christian Chabannon)
Empowering Healthcare through Patient Advocacy (with Jan Geissler)
Off-the-shelf CAR T-cells from iPSCs (with Prof Maria Themeli)
AIDPATH – AI automated CAR T-cell manufacturing (with Dr Carmen Sanges)
Hematology Portraits: prof. Elizabeth Macintyre
Is low-risk MDS really low risk? (with Prof Uwe Platzbecker)
MRD Monitoring in MDS Patients (with Prof Arjan van de Loosdrecht)
Hematology Portraits: prof. Martin Dreyling
MDS Pathophysiology and the Role of Immune Dysfunction (with Dr Shahram Kordasti)
Mapping Rare Anemia Patient Data: RADeep (with Dr. María del Mar Mañú Pereira)
Hematology Portraits: prof. Antonio Almeida
Targeting the Immune System in MDS (featuring Prof Dominik Wolf)
Accelerating Clinical Trials with AI (with Dr Jan Moritz Middeke)
The Current Diagnostic Approach to MDS (with Dr Onima Chowdhury)
Hematology Portraits: Prof Brian Huntly
Mental Health in CLL
Patient Perspectives on Gene Therapy for Sickle Cell Disease and B-Thalassemia
Hematology Portraits: Prof Kostas Stamatopoulos
Management of High-risk MDS: Seeking Clarity for Classification and Treatment
Hematopoietic Stem Cells in Health, Aging and Malignancy: Focus on Metabolism (EHA2024)
Innovative Trial Design (EHA2024)
Hereditary Hematological Malignancies (HHMs): A New Era of Discovery in MDS and AML (EHA2024)
Hairy Cell Leukemia (HCL): Treatment of Relapsed Disease (EHA2024)
Iron Metabolism in Myelodysplastic Syndrome (MDS)
First-line Treatment of Primary Central Nervous System Lymphoma (PCNSL) (EHA2024)
Optimizing Global Care for Women with von Willebrand Disease (VWD) (EHA2024)
Iron and Infections: Back to the Future (EHA2024)
Long-term Outcomes in the Chemo-free era for Acute Promyelocytic Leukemia (EHA2024)
Thrombotic thrombocytopenic purpura (TTP): Is plasmapheresis history?
The Role of Artificial Intelligence in Hematology (featuring Dr Gregor Hormann)
From MDS to AML: Genetics of Progression (featuring Prof Lars Bullinger)
Screening for Sickle Cell Disease (with Prof David Rees)
The Environmental Impact on Hematology Practice (with Dr Stephen Hibbs)
Synthetic Patients: The Future of Clinical Trials?
Innovative tools for Disease Monitoring in Multiple Myeloma
Hematology Portraits: Prof Ivo Touw
Preventing Venous Thromboembolism (VTE) in Pregnant Women
Gene Therapy for Hemophilia
AI-driven Morphology in Hematology
Regulatory Landscape for CAR T-cell Therapy
Point-of-care CAR T-cell Manufacturing
Processes in CAR T-cell Therapy
CAR T-cell Therapy for Children with ALL
CAR T-cell Therapy in AML: State of the Art
Ethical Considerations in CAR T-cell Therapy
CAR T-cell Therapy - A Patient's Perspective
Developments in CAR T-cell Therapy
Precision Medicine in Myelodysplastic Syndromes (MDS)
Diversity, Equity, and Inclusion in Hematology
Trends in CAR T-cell Therapy
Precision Medicine in Chronic Lymphocytic Leukemia (CLL)
Precision Medicine in Rare Hematological Diseases: Pyruvate Kinase Activators
Precision Medicine in Follicular Lymphoma
Precision Medicine in Multiple Myeloma
Precision Medicine in Myeloproliferative Neoplasms
Precision Medicine and Clonal Hematopoiesis
Precision Medicine: Hepcidin Mimetics for Polycythemia Vera Treatment
Precision Medicine in Inherited Bone Marrow Failure Syndromes
The Whats in Scientific Publishing
The New Classification of Hemochromatosis: Why and How
Diversity, equity, and inclusion: Why this is important?
Unraveling Autoimmune Neutropenia: From Childhood to Adulthood
Navigating the World of Hematology Research: from Mentorship to Work-Life Balance
Myelodysplastic Syndrome (MDS) with Prof Kirsten Grønbæk
Immune cell therapies and targeted therapies in AML
Patient Communication and Self Care
Building prognostic models using big data with Prof Kimmo Porkka
Myeloma - Prof Jorge Sierra
Lymphoma - Dr Umut Yilmaz
How to Get Started in Hematology Research - Dr Anastasia Conti, Assoc Prof Maria Paola Martelli and Dr Simona Valletta
Pediatric Hematology - Dr Mirjam Belderbos
Iron metabolism: physiology and pathology
Pathogenesis and Management of Acute Chest Syndrome (ACS) in SCD
EHA Unplugged: MDS Classification and Risk Assessment
New Treatment of Iron Metabolism Defects: A Focus on Anemia of Inflammation
Latest Innovations and Future Perspectives in CAR-T Therapy
Current CAR-T Treatment for Lymphomas Focusing on DLBCL
Clinical Management of CAR-T Therapy in Myeloma
Challenges in receiving CAR-T treatment: Patient's perspective
Ph+ acute lymphoblastic lymphoma and the immune system in hematological neoplasms.
CAR-T Treatment in Myeloma: State of the Art
Reasons for Failure and Relapse and Mechanisms of Resistance in CAR-T
Economic Aspects of CAR-T: Challenges and Solutions
Update on CAR-T Therapies in Acute and Chronic Leukemias
Spotlight Talks: How I Treat Absolute Iron Deficiency in Inflammatory Disorders
Overview of the Current CAR-T Landscape
Papers Unplugged: Precision Medicine and Myeloid Neoplasms
Debate: Gene Addition or Gene Editing for Hemoglobinopathies?
What's in Store for Lymphoid Malignancies?
Spotlight Talks: Postpartum Hemorrhage (PPH)
Papers Unplugged: The Perspectives of Doctors and Patients in the Treatment of CLL
Papers Unplugged: Precision Medicine in AML
Debate: Should Low Risk PV-MF Patients be Treated?
Health Technology Assessment (HTA)
Spotlight Talks: New Agents for the Treatment of Thalassemia
Papers Unplugged: What's New in the Treatment of CLL?
Spotlight Talks: Updates on the Classification of Hematolymphoid Neoplasms—Myelodysplastic Syndromes
Papers Unplugged: TIF Guidelines for the Management of Patients with Transfusion-Dependent Thalassemia (TDT)
Spotlight Talks: Updates on the Classification of Hematolymphoid Neoplasms—Lymphoid Diseases
Papers Unplugged: Is CAR-T Economically Sustainable?
Papers Unplugged: What Ever Happened to Plan S?
Papers Unplugged: CHIP and Associated Risk in Elderly Patients
Papers Unplugged: EHA and War in Ukraine
Papers Unplugged: Precision Medicine and Hemoglobinopathies
Naive CLL
Thrombosis - Bleeding in Cancer
The Microbiome in HCT
Diagnosing Erythrocytosis
Clinical Trials of the Future (Clinical Trial)
Cutaneous T Cell Lymphoma (CTCL) Episode 1: Presentation and Diagnosis
Cutaneous T Cell Lymphoma (CTCL) Episode 2: Treatment
Circulating Tumor DNA
Treating CML in Developing Countries
Less is More - Transfusion
Chronic Myeloid Leukemia (Naomi)
All Good Things Must Come to an End: How and When to End a Clinical Trial (Clinical Trial)
Iron Deficiency: Perioperative
Documentation and authorization: Safeguarding the Credibility of Clinical Trials (Clinical Trial)
Ethical Issues Associated with Treating Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths)
Sponsor: A Role to Take Seriously (Clinical Trial)
Hematological Changes in Older Adults (Aging Patient: Dispelling Myths)
Patient Support: Relate and Create (Clinical Trial)
Treatment of Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths)
The Paper Trail (CRO) (Clinical Trial)
Patient Assessment In Older Adults (Aging Patient: Dispelling Myths)
Multiple Myeloma in Underserved Populations (Episode 3)
What matters in a trial design? (Clinical Trial)
Aging and Clonal Diseases (Aging Patient: Dispelling Myths)
Iron Deficiency: Women
Iron Deficiency: Chronic Kidney Disease
Iron Deficiency: Heart Failure
HSCT in Multiple Myeloma
Multiple Myeloma in Underserved Populations (Episode 2)
Chronic Lymphocytic Leukemia (CLL)
Chronic Myeloid Leukemia (CML)
SCD: What Physicians Can Learn From Patients And Carriers (Episode 3)
Multiple Myeloma in Underserved Populations (Episode 1)
SCD: What Physicians Can Learn From Patients And Carriers (Episode 2)
BCR-ABL1-like ALL
ALL Hope For The Future
Iron Homeostasis in Host Defense and Inflammation
SCD: What Physicians Can Learn From Patients And Carriers (Episode 1)
Impact of Social Stigma on Coping with SCD
Interventions in Adolescent SCD
Sickle Cell Disease in Pregnancy
HSCT in Paroxysmal Nocturnal Hemoglobinuria
HSCT in Severe Aplastic Anemia
Engraftment and Chimerism following HSCT
Infections in HSCT
Graft-versus-Host Disease in HSCT
The History of HSCT